{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:02:59Z","timestamp":1761894179870},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s00345-005-0005-7","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T16:16:40Z","timestamp":1127233000000},"page":"253-256","source":"Crossref","is-referenced-by-count":20,"title":["Progression delay in men with mild symptoms of bladder outlet obstruction: a comparative study of phytotherapy and watchful waiting"],"prefix":"10.1007","volume":"23","author":[{"given":"Bob","family":"Djavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan Kit","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Chaudry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Reissigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Anagnostou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariborz","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Waldert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Marihart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Harik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Marberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,9,21]]},"reference":[{"key":"5_CR1","unstructured":"Oishi K, Boyle P, Barry MJ (1998) Epidemiology and natural history of BPH. In: Denis L, Murphy G, Khoury S (eds) 3rd International consultation on BPH. Jersy, Scientific Communications International"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0090-4295(01)01506-0","volume":"59","author":"G Welsch","year":"2000","unstructured":"Welsch G, Weinger K, Barry MJ (2000) Quality-of-life impact of lower urinary tract symptom severity: results from the health professionals follow-up study. Urology 59:245\u2013250","journal-title":"Urology"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0090-4295(97)00717-6","volume":"51","author":"CJ Girman","year":"1998","unstructured":"Girman CJ, Jacobsen SJ, Tsukamoto T, Richard F, Garraway WM, Sagnier PP, Guess HA, Rhodes T, Boyle P, Lieber MM (1998) Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 51:428\u2013436","journal-title":"Urology"},{"key":"5_CR4","unstructured":"McConnell JD, Barry MJ, Bruskewitz RC (1994) Benign prostatic hyperplasia: diagnosis and treatment. Clinical practice guideline, number 8. AHCPR publication no. 94-0582. Rockville, MD, Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services"},{"key":"5_CR5","unstructured":"Djavan B, Wammack R, Dobrovits M, Bagheri F, Kramer G, Hruby S, Chaudry A, Andreas Reissigl, Alexandre Zlotta, Marberger M (2002) Predictors of progression in men with mild symptoms of bladder outlet obstruction. J Urol 167(Suppl):268, A1054"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jama.1995.03520320015008","volume":"273","author":"C Marwick","year":"1995","unstructured":"Marwick C (1995) Growing use of medicinal botanicals forces assessment by drug regulators. JAMA 273:607\u2013609","journal-title":"JAMA"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.279.19.1548","volume":"279","author":"JA Astin","year":"1998","unstructured":"Astin JA (1998) Why patients use alternative medicine: results of a national study. JAMA 279:1548\u20131553","journal-title":"JAMA"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/1097-4679(199405)50:3<458::AID-JCLP2270500318>3.0.CO;2-V","volume":"50","author":"A Furnham","year":"1994","unstructured":"Furnham A, Forey J (1994) The attitudes, behaviors, and beliefs of patients of conventional vs complementary (alternative) medicine. J Clin Psychol 50:458\u2013469","journal-title":"J Clin Psychol"},{"key":"5_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00044011-199509050-00007","volume":"9","author":"JL Descotes","year":"1995","unstructured":"Descotes JL, Rambeaud JJ, Deschaseaux P (1995) Placebo controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after exclusion of placebo responders. Clin Drug invest 9:291\u2013297","journal-title":"Clin Drug invest"},{"key":"5_CR10","first-page":"15","volume":"4","author":"J Cukier","year":"1999","unstructured":"Cukier J, Ducasso J, Le Guillou M (1999) Permixon versus placebo. Results from multicenter trial. CR Ther Pharmacol Clin 4:15\u201321","journal-title":"CR Ther Pharmacol Clin"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<231::AID-PROS4>3.0.CO;2-E","volume":"29","author":"JC Carraro","year":"1996","unstructured":"Carraro JC, Raynaud JP, Koch G, Chisholm GD, Di Silverio F, Teillac P, Da Silva FC, Cauquil J, Chopin DK, Hamdy FC, Hanus M, Hauri D, Kalinteris A, Marencak J, Perier A, Perrin P (1996) Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostatic hyperplasia: a randomized international study of 1098 patients. Prostate 29:231\u2013240","journal-title":"Prostate"},{"key":"5_CR12","first-page":"97","volume":"48","author":"M Grasso","year":"1995","unstructured":"Grasso M, Montesano A, Buonaguidi A, Castelli M, Lania C, Rigatti P, Rocco F, Cesana BM, Borghi C (1995) Comparative effects of alfuzosin versus Serona repens in the treatment of benign prostate hyperplasia. Arch Esp Urol 48:97\u2013103","journal-title":"Arch Esp Urol"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0090-4295(01)01442-X","volume":"58","author":"GS Gerber","year":"2001","unstructured":"Gerber GS, Kuznetsov D, Johnson BC, Burstein JD (2001) Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Urology 58:960\u2013965","journal-title":"Urology"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","volume":"349","author":"JD McConnell","year":"2003","unstructured":"McConnell JD, Roehrborn CG, Baustita OM, Andriole GL, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM (2003) The long-term effect on doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349:2387\u20131398","journal-title":"N Engl J Med"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0090-4295(99)00593-2","volume":"55","author":"P Boyle","year":"2000","unstructured":"Boyle P, Robertson C, Lowe F, Roehtborn C (2000) Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 55:533\u2013539","journal-title":"Urology"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0090-4295(99)80007-7","volume":"5","author":"SA Kaplan","year":"1995","unstructured":"Kaplan SA, Goluboff ET, Olsson CA, Deverka PA, Chmiel JJ (1995) Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia. Urology 5:398\u2013405","journal-title":"Urology"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-005-0005-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-005-0005-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-005-0005-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:35:33Z","timestamp":1559050533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-005-0005-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1007\/s00345-005-0005-7","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}